Cancer

CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment

Segment featuring members of the CNS management team and leading Neuro-Oncologist and Key Opinion Leader, Dr. Samuel GoldlustAccess the segment…

1 year ago

International Myeloma Foundation Launches Clinical Trial Matching Engine in Partnership with SparkCures

SparkCures’ best-in-class clinical trial matching and navigation service is now accessible via myeloma.org.STUDIO CITY, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE)…

1 year ago

Alpha Tau Treats First Patient with Recurrent Lung Cancer

JERUSALEM, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the…

1 year ago

Aprea Therapeutics Announces Presentations at EORTC-NCI-AACR International Conference on Molecular Targets and Therapeutics

DOYLESTOWN, Pa., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company…

1 year ago

Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program

Company’s VP of Education and Global Training Named Chairman of ASRM Corporate Member CouncilATLANTA, Oct. 10, 2024 (GLOBE NEWSWIRE) --…

1 year ago

Cantargia’s Strong Phase 2 Clinical Data in Pancreatic Cancer with Nadunolimab Published in Clinical Cancer Research

LUND, SWEDEN / ACCESSWIRE / October 10, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced the…

1 year ago

CZI, State and City Leaders Launch Chan Zuckerberg Biohub New York

CZ Biohub New York is catalyzing collaboration among scientists in the New York area from Columbia University, The Rockefeller University,…

1 year ago

Proteotype Awarded £1.5 Million Grant to Advance Early Cancer Detection with Innovative Enlighten® Test

CAMBRIDGE, United Kingdom, Oct. 9, 2024 /PRNewswire/ -- Proteotype Diagnostics Ltd, in collaboration with the University of Southampton, has been awarded…

1 year ago